Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Nordson holds stock target with Atrion acquisition plan

EditorNatashya Angelica
Published 05/29/2024, 01:56 AM
© Reuters.
NDSN
-

Tuesday, Nordson (NASDAQ:NDSN) Corporation (NASDAQ:NDSN), a leading supplier of precision dispensing equipment, maintained its Buy rating and a $295.00 price target, following the announcement of its plans to acquire Atrion Corporation. The deal is valued at approximately $800 million, or around 15 times Atrion's estimated 2024 EBITDA, including the synergies expected within the first two years of Nordson's ownership.

The acquisition is seen as a strategic move for Nordson, as Atrion's product lines are well-aligned with the company's long-term organic growth trajectory, particularly in the medical sector. Atrion specializes in products such as infusion fluid delivery and single-use OEM components, interventional inflation devices, and myocardial protection devices, among other consumables.

Upon completion of the transaction, the medical end market is anticipated to represent approximately 26% of Nordson's pro forma (PF) sales. This represents a significant increase and highlights the company's commitment to expanding its presence in the medical equipment industry.

The endorsement of the acquisition comes with expectations of beneficial secular trends that will support both Nordson's and Atrion's growth in the medical field. The focus on this sector is timely, considering the increasing demand for medical devices and technology.

The price target of $295.00 suggests a positive outlook on Nordson's stock, reflecting confidence in the company's strategic direction and the anticipated financial benefits of the Atrion acquisition. Nordson's shares continue to be watched closely by investors as the company progresses with its expansion plans in the medical technology space.

InvestingPro Insights

Nordson Corporation's (NASDAQ:NDSN) strategic acquisition of Atrion Corporation is complemented by a solid financial profile, as indicated by real-time data from InvestingPro. With a market capitalization of $13.46 billion and a healthy P/E ratio standing at 27.71, Nordson demonstrates stability in its valuation. The company's impressive gross profit margin, which has reached 55.01% over the last twelve months as of Q2 2024, further underscores its operational efficiency and potential for continued profitability.

Two noteworthy InvestingPro Tips for Nordson include the company's impressive track record of raising its dividend for 31 consecutive years and maintaining dividend payments for 45 consecutive years. This consistency is a testament to Nordson's financial strength and commitment to shareholder returns. Moreover, the company's liquid assets surpassing short-term obligations suggest a robust balance sheet, providing flexibility for strategic moves like the Atrion acquisition.

Investors seeking deeper insights can find additional InvestingPro Tips that may influence their investment decisions. For those interested in unlocking the full range of analysis, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. Currently, there are 10 more InvestingPro Tips available, offering comprehensive perspectives on Nordson's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.